AC
Amanda Chen
Lead Health Editor
Amanda leads editorial direction at GLP Agonists. Eight years covering telehealth, digital-health access, and direct-to-consumer pharmacy.
Read full bio →The team
Updated July 23, 2026
Fact-checked by Dr. J. Adam, MD on . See our fact-checking policy.
The journalists, physician, and pharmacist behind GLP Agonists' editorial coverage. Every person listed here has a published bio, named credentials, and a documented role in the editorial process — because anonymous reviewers can't be held accountable, and accountability is the foundation of trustworthy health journalism.
Amanda leads editorial direction at GLP Agonists. Eight years covering telehealth, digital-health access, and direct-to-consumer pharmacy.
Read full bio →Dr. J. Adam is a U.S.-licensed physician serving as Medical Director at NexLife and clinical reviewer for all medication, dosing, and contraindication content at GLP Agonists.
Read full bio →Dr. Berg is a licensed pharmacist with twelve years in clinical pharmacy, focused on cardiometabolic and endocrine medications and on the standards governing compounded-medication preparation.
Read full bio →Maria specializes in healthcare pricing transparency and insurance navigation. She researches and fact-checks every pricing claim that appears on GLP Agonists.
Read full bio →Every page on GLP Agonists is written by a named editor, fact-checked by a named clinical reviewer, and dated with the day of last review. We publish those names because health journalism without accountability is just marketing with footnotes.
GLP Agonists accepts pitches from licensed clinicians, journalists with health-beat experience, and researchers with peer-reviewed work in cardiometabolic medicine. Pitches go to glpagonists@gmail.com with the subject line "PITCH:" and a one-paragraph summary. We do not accept ghostwritten or AI-generated submissions.